H. Adle-biassette et al., Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage, NEUROP AP N, 25(2), 1999, pp. 123-133
To characterize the distribution of apoptotic neurons and their relationshi
ps with the stage of disease, a history of HIV-dementia, and the degree of
productive HIV infection, microglial activation and axonal damage, we exami
ned the brains of 40 patients. Samples of frontal and temporal cortex, basa
l ganglia and brain stem were taken post-mortem from 20 patients with AIDS
(including three with HIV-dementia, and eight with cognitive disorders that
did not fulfil the criteria for HIV-dementia), 10 HIV-positive asymptomati
c cases and 10 seronegative controls. Neuronal apoptosis was demonstrated b
y in situ end labelling in 18 AIDS cases and two pre-AIDS cases; a single a
poptotic neuron was present in the temporal cortex of a control. Semiquanti
tative evaluation showed that the severity of neuronal apoptosis in the cer
ebral cortex correlated with the presence of cerebral atrophy, but not with
a history of HIV dementia. There was no global quantitative correlation be
tween neuronal apoptosis and HIV encephalitis or microglial activation. How
ever, there was some topographical correlation between these changes. In th
e basal ganglia, apoptotic neurons were much more abundant in the vicinity
of multinucleated giant cells and/or p24 expressing cells. Microglial activ
ation was constantly present in these areas. Axonal damage was identified u
sing beta-amyloid-precursor protein (beta APP) immunostaining in 17 AIDS an
d eight pre-AIDS brains. Although no global quantitative correlation could
be established between axonal damage and neuronal apoptosis there was an ob
vious topographic correlation supporting the view that axonal damage, eithe
r secondary to local microglial activation or due to the intervention of sy
stemic factors, may also contribute to neuronal apoptosis.